Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Turnstone Biologics

Turnstone Biologics?uq=w9if130k
2015 FOUNDED
PRIVATE STATUS
21-30 EMPLOYEES
Series B LATEST DEAL TYPE
$41.4M LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of viral immunotherapies designed to improve survival for patients with cancer. The company's immunotherapies combine a bio-selected and engineered oncolytic virus to directly lyse tumors with a potent vaccine technology to drive tumor-antigen specific T-cell responses, enabling bio-medical professionals to generate immune responses, treat cancer and modulate tumor environment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 787 Bank Street
  • 2nd Floor
  • Ottawa, Ontario K1S 3V5
  • Canada

+1 (613) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Turnstone Biologics’s full profile, request a free trial.

Turnstone Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 02-Nov-2016 $41.4M 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 28-Oct-2015 000.00 000.00 Completed Startup
1. Angel (individual) 04-May-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Turnstone Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
F-Prime Capital Partners Venture Capital Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
Versant Venture Management Venture Capital Minority 000 0000 000000 0
Fight Against Cancer Innovation Trust Other Minority 000 0000 000000 0

Turnstone Biologics Executive Team (12)

Name Title Board
Seat
Contact
Info
Sammy Farah Ph.D Chief Executive Officer, President & Board Member
Jane Henderson Chief Financial Officer
Jane Pritchett Henderson Chief Financial Officer
Kristian Elverum Chief Business Officer
Brian Lichty Ph.D Co-Founder and Senior Vice President, Basic Research

1 Former Executive

You’re viewing 5 of 12 executives. Get the full list »

Turnstone Biologics Board Members (7)

Name Representing Role Since Contact
Info
Benjamin Auspitz F-Prime Capital Partners Board Member 000 0000
Bradley Bolzon Ph.D Versant Venture Management Chairman 000 0000
Jeff Courtney Fight Against Cancer Innovation Trust Board Member 000 0000
Jerel Davis Ph.D Versant Venture Management Board Member 000 0000
John Bell Ph.D Self Co-Founder & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »